期刊文献+

循环DNA在结直肠癌中的诊断价值 被引量:1

下载PDF
导出
摘要 目的探讨结直肠癌患者循环DNA含量的特点。方法选择结直肠癌患者42例(研究组)、结直肠腺瘤患者18例(良性肿瘤组)和健康对照者30例(对照组),提取血浆DNA行血浆DNA定量,并分析血浆DNA水平与临床病理参数的相关性及术前术后的变化。结果对照组、良性肿瘤组与研究组循环DNA水平分别为(15.01±8.61)、(83.72±95.80)、(645.32±528.92)ng/ml,研究组循环DNA水平增高(P<0.01)。结直肠癌患者血浆循环DNA水平与肝、肺转移有相关性。结直肠癌术后患者血浆循环DNA水平较术前下降(P<0.05)。结论结直肠癌患者的循环DNA含量增高且与肿瘤的远位转移相关;结直肠癌术后循环DNA水平降低。
作者 王文渊
机构地区 山西省肿瘤医院
出处 《山东医药》 CAS 北大核心 2010年第8期59-60,共2页 Shandong Medical Journal
  • 相关文献

参考文献4

  • 1Sozzi G, Conte D, Leon M, et al. Quantification af free circulating DNA as a diagnostic marker in lung cancer [J]. J Glln Oncol, 2003,21 ( 21 ) :3902-3908.
  • 2Chang HW, Lee-SM, Goodman SN, et al. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer [J]. J Natl Cancer Inst, 2002, 4(22) :1697-1703.
  • 3Sozzi G, Musso K, Ratcliffe C, et al. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis [ J ]. Clin Cancer Res, 1999,5 (10) : 2689 -2692.
  • 4Lecomte T, Berger A, Zinzindohoue F, et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis [ J]. Int J Cancer, 2002, 100(5) :542-548.

同被引文献12

  • 1刘敏,陆化,蒋明,刘志安,严枫,赵建华.食管癌患者循环DNA的定量分析及其临床应用价值[J].临床检验杂志,2006,24(5):326-328. 被引量:5
  • 2秦楚,王朝霞.非小细胞肺癌个体化治疗研究进展[J].中华临床医师杂志,2013,7(21):9681-9686.
  • 3FLEISCHHACKER M,SCHMIDT B.Circulating nucleic acids(CNAs)and cancer-a survey[J].Biochim Biophys Acta,2007,1775(1):181-232.
  • 4ASHUTOSH K P,MANISHA B,SACHIN K,et al.Circulating cell free DNA in plasma/Serum of lung cancer patients as a potential screening and prognostic tool[J].Clin Chem,2006,52(10):1883-1842.
  • 5WANG J Y,HSIEH J S,CHANG MY,et al.Molecular detection of APC,K-ras,and P53 mutations in the serum of colorectal cancer patients as circulating biomarkers[J].World J Surg,2004,28(7)):721-726.
  • 6LACROIX J,BECKER H D,WOERNER S M,et al.Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by reproGRP-specific RT-PGR[J].Int J Cancer,2001,92(1): 1-8.
  • 7PACI M,MARAMOTTI S,BELLESIA E,et al.Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer[J].Lung Cancer,2009,64(1):92-97.
  • 8YOON K A,PARK S,LEE S H,et al.Comparison of circulating plasma DNA levels between lung cancer patients and healthy con-trols[J].J Mol Diagn,2009,11(3):182-185.
  • 9VAN DER DRIFT M A,HOL B E,KLAASSEN C H,et al.Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer[J].Lung Cancer,2010,68(2):283-287.
  • 10ZIEGLER A,ZANGEMEISTER WITTKE U,STAHEL R A.Circulating DNA: a new diagnostia gold mine?[J].Cancer Treat Rev,2002,28(5):255-271.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部